These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Pathobiology of dysplasia in chronic inflammatory bowel disease: Current recommendations for surveillance of dysplasia]. Raithel M; Weidenhiller M; Schwab D; Müller S; Hahn EG Z Gastroenterol; 2001 Oct; 39(10):861-75. PubMed ID: 11605156 [TBL] [Abstract][Full Text] [Related]
6. Studies in longstanding ulcerative colitis with special reference to malignant transformation of the colorectal mucosa. Löfberg R Acta Chir Scand Suppl; 1989; 552():1-45. PubMed ID: 2800882 [TBL] [Abstract][Full Text] [Related]
8. [Risk factors for ulcerative colitis associated colorectal cancers in a Hungarian cohort of ulcerative colitis patients]. Lakatos L; Mester G; Erdélyi Z; David G; Pandúr T; Balogh M; Fischer S; Vargha P; Lakatos PL Orv Hetil; 2006 Jan; 147(4):175-81. PubMed ID: 16515026 [TBL] [Abstract][Full Text] [Related]
9. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Itzkowitz SH; Yio X Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G7-17. PubMed ID: 15194558 [TBL] [Abstract][Full Text] [Related]
10. Cancer surveillance in inflammatory bowel disease: new molecular approaches. Risques RA; Rabinovitch PS; Brentnall TA Curr Opin Gastroenterol; 2006 Jul; 22(4):382-90. PubMed ID: 16760754 [TBL] [Abstract][Full Text] [Related]
11. [Premalignant and malignant changes in idiopathic inflammatory bowel disease]. Knezević-Usaj S; Panisić M; Tarabar D; Cuk V; Brajuković G; Petrović M Acta Chir Iugosl; 2000; 47(1-2):43-50. PubMed ID: 10953365 [TBL] [Abstract][Full Text] [Related]
13. Cancer biology in ulcerative colitis and potential use in endoscopic surveillance. Shapiro BD; Lashner BA Gastrointest Endosc Clin N Am; 1997 Jul; 7(3):453-68. PubMed ID: 9177146 [TBL] [Abstract][Full Text] [Related]
14. Review article: The relevance of surveillance endoscopy in long-lasting inflammatory bowel disease. Vleggaar FP; Lutgens MW; Claessen MM Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():47-52. PubMed ID: 18081648 [TBL] [Abstract][Full Text] [Related]
16. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease. Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187 [TBL] [Abstract][Full Text] [Related]
17. Surveillance of patients with chronic ulcerative colitis. WHO Collaborating Centre for the Prevention of Colorectal Cancer. Levin B; Lennard-Jones J; Riddell RH; Sachar D; Winawer SJ Bull World Health Organ; 1991; 69(1):121-6. PubMed ID: 1905205 [TBL] [Abstract][Full Text] [Related]
18. Chemoprevention of colorectal cancer in inflammatory bowel disease? A potential role for folate. Mouzas IA; Papavassiliou E; Koutroubakis I Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):421-5. PubMed ID: 9789142 [TBL] [Abstract][Full Text] [Related]